About
Patient-specific Breast Cancer Locator
Areas of Focus
Categories
Surgical DeviceBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
1,528
By Phase
NA: 3
By Status
RECRUITING: 3COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06461663Lead Sponsor
CairnSurgical Breast Cancer Locator (BCL) Post-Market Study
NACompleted
35 participants
Started: Jul 22, 2022 · Completed: Apr 19, 2024
NCT05131607Collaborator
21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial
NAActive, not recruiting
45 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2024
NCT04397185Lead Sponsor
Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
NARecruiting
448 participants
Started: Dec 23, 2020 · Completed: Apr 30, 2025
NCT04548375Lead Sponsor
Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol
N/ARecruiting
500 participants
Started: Nov 1, 2020 · Completed: Nov 1, 2026
NCT03604133Collaborator
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
N/ARecruiting
500 participants
Started: Aug 24, 2017 · Completed: Aug 24, 2028
Locations (1)
Headquarters
Lebanon, NH, United States
Map
Loading map...